RM vs SRPT · P/E 7.5, rev $588.5M vs rev $1.90B
Regional Management Corp (RM) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Regional Management Corp (RM) is a credit services company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported RM revenue for 2024-12-31 was $588.5M. Net income was $41.2M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. RM currently screens at market cap $339.8M and trailing P/E 7.5.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
RM currently screens at market cap $339.8M and trailing P/E 7.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the RM and SRPT stock pages for the full models.
Not investment advice.